FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Amphotericin B Liposome for Injection Recall

Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceu…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Jul 5, 2023
Recall ID
D-0891-2023
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Amphotericin B Liposome for Injection starting May 30, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0891-2023 on Jul 5, 2023. Reason: Subpotent drug. Status: Terminated.

Why it was recalled

Subpotent drug

Product description

Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01

Lot numbers, UPCs & expiration codes

Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025

Where it was sold

USA nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0891-2023
Classification
Class II
Status
Terminated
Recall initiated
May 30, 2023
FDA report date
Jul 5, 2023
Quantity
12960 vials
Recall type
N/A
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0891-2023, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
92425
Address
2 Independence Way
Code information
Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025
Postal code
08540-6620
Report date
Jul 5, 2023
Product type
Drugs
Recall number
D-0891-2023
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
12960 vials
Termination date
Dec 18, 2023
Reason for recall
Subpotent drug
Product description
Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01
Distribution pattern
USA nationwide
Recall initiation date
May 30, 2023
Center classification date
Jun 29, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0891-2023, published Jul 5, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls